Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Molecular Cancer Research : MCR|February 9, 2022
Targeted Rejuvenation of Exhausted Chimeric Antigen Receptor T Cells Regresses Refractory Solid TumorsQian Luo, John V Napoleon, Xin Liu, et al.Frontiers in Immunology|November 6, 2023
Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growthRami Alfar, John V Napoleon, Imrul Shahriar, et al.Journal of Medicinal Chemistry|February 17, 2026
A Folate Receptor β-Targeted TLR7 Agonist Significantly Augments Checkpoint Inhibitor Potencies by Reprogramming Tumor-Associated Macrophages and Myeloid-Derived Suppressor CellsJohn V Napoleon, Rami Alfar, Fenghua Zhang, et al.Scientific Reports|May 20, 2022
Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligandsYingwen Hu, Danyang Chen, John V Napoleon, et al.Frontiers in Immunology|March 7, 2022
Repolarization of Tumor-Infiltrating Myeloid Cells for Augmentation of CAR T Cell TherapiesWeichuan Luo, John V Napoleon, Fenghua Zhang, et al.Chemical Communications (Cambridge, England)|May 12, 2021
Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive mannerJohn V Napoleon, Sarbjit Singh, Sandeep Rana, et al.Heliyon|February 8, 2024
Biological evaluation of novel side chain containing CQTrICh-analogs as antimalarials and their development as <i>Pf</i>CDPK1 kinase inhibitorsIram Irfan, Amad Uddin, Ravi Jain, et al.European Journal of Medicinal Chemistry|June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapySatish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.Frontiers in Immunology|February 22, 2024
Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironmentFenghua Zhang, Bo Huang, Sagar M Utturkar, et al.Pageof 1